Registro:

Referencias:

• Appel, J.B., Freedman, D., Tolerance and cross-tolerance among psychotomimetic drugs (1968) Psychopharmacologia, 13, pp. 267-274. , 5679628
• Backman, T.W.H., Cao, Y., Girke, T., ChemMine tools: an online service for analyzing and clustering small molecules (2011) Nucleic Acids Res, 39, pp. W486-W491. , 21576229
• Baker, L.E., Hallucinogens in drug discrimination (2017) Current Topics in Behavioral Neurosciences, pp. 201-219. , Geyer M.A., Ellenbroek B.A., Marsden C.A., Barnes R.E., Andersen S.L., (eds), Berlin, Springer, “,”, eds
• Balestrieri, A., Fontanari, D., Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148 (1959) AMA Arch. Gen. Psychiaty, 1, pp. 279-282. , 13796178
• Barker, S.A., Monti, J.A., Christian, S.T., N, N-dimethyltryptamine: an endogenous hallucinogen (1981) Int. Rev. Neurobiol, 22, pp. 83-110. , 6792104
• Bastian, M., Heymann, S., Jacomy, M., Gephi: an open source software for exploring and manipulating networks (2009) ICWSM, 8, pp. 361-362
• Beck, O., Helander, A., Karlson-Stiber, C., Stephansson, N., Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions (1998) J. Anal. Toxicol, 22, pp. 45-49. , 9491968
• Beisken, S., Meinl, T., Wiswedel, B., de Figueiredo, L.F., Berthold, M., Steinbeck, C., KNIME-CDK: workflow-driven cheminformatic (2013) BMC Bioinformatics, 14, p. 257. , 24103053
• Berthold, M.R., Cebron, N., Dill, F., Gabriel, T.R., Kötter, T., Meinl, T., KNIME—the Konstanz information miner: version 2.0 and beyond (2009) ACM SIGKDD Expl. Newsl, 11, pp. 26-31
• Bird, S., NLTK: the natural language toolkit (2006) Proceedings of the COLING/ACL on Interactive Presentation Sessions, pp. 69-72. , Stroudsburg, PA: Association for Computational Linguistics, “,”
• Blair, J.B., Kurrasch-Orbaugh, D., Marona-Lewicka, D., Cumbay, M.G., Watts, V.J., Barker, E.L., Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines (2000) J. Med. Chem, 43, pp. 4701-4710. , 11101361
• Boström, J., Hogner, A., Schmitt, S., Do structurally similar ligands bind in a similar fashion? (2006) J. Med. Chem, 49, pp. 6716-6725. , 17154502
• Bowdle, A.T., Radant, A.D., Cowley, D.S., Kharasch, E.D., Strassman, R.J., Roy-Byrne, P.P., Psychedelic effects of ketamine in healthy volunteers relationship to steady-state plasma concentrations (1998) Anesthesiology, 88, pp. 82-88. , 9447860
• Breakspear, M., Dynamic models of large-scale brain activity (2017) Nat. Neurosci, 20, pp. 340-352. , 28230845
• Bylund, D.B., Toews, M.L., Radioligand binding methods: practical guide and tips (1993) Am. J. Physiol, 265, pp. L421-L429. , 8238529
• Carbonaro, T.M., Eshleman, A.J., Forster, M.J., Cheng, K., Rice, K.C., Gatch, M.B., The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice (2015) Psychopharmacology, 232, pp. 275-284. , 24985890
• Carhart-Harris, R.L., Leech, R., Hellyer, P.J., Shanahan, M., Feilding, A., Tagliazucchi, E., The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (2018) Front. Hum. Neurosci, 8, p. 20. , 24550805
• Chen, X., Reynolds, C.H., Performance of similarity measures in 2D fragment-based similarity searching: comparison of structural descriptors and similarity coefficients (2002) J. Chem. Inf. Comput. Sci, 42, pp. 1407-1414. , 12444738
• Cheng, A.C., Castagnoli, N., Jr., Synthesis and physicochemical and neurotoxicity studies of 1–(4-substituted-2,5-dihydroxyphenyl)-2-aminoethane analogs of 6-hydroxydopamine (1984) J. Med. Chem, 27, pp. 513-520. , 6423824
• Chialvo, D.R., Emergent complex neural dynamics (2010) Nat. Phys, 6, pp. 744-750
• Conn, P.J., Sanders-Bush, E., Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site (1986) J. Neurosci, 6, pp. 3669-3675. , 3025382
• Coutts, R.T., Malicky, J.L., The synthesis of some analogs of the hallucinogen 1- (2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) (1973) Can. J. Chem, 51, pp. 1402-1409
• Coyle, J., Presti, D., Baggott, M., Quantitative analysis of narrative reports of psychedelic drugs (2012) arXiv, , 1206.0312 [q-bioQM]
• Delille, H.K., Becker, J.M., Burkhardt, S., Bleher, B., Terstappen, G.C., Schmidt, M., Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades (2012) Neuropharmacology, 62, pp. 2184-2191. , 22300836
• Dittrich, A., The standardized psychometric assessment of altered states of consciousness (ASCs) in humans (1998) Pharmacopsychiatry, 31, pp. 80-84. , 9754838
• Dos Santos, R.G., Osório, F.L., Crippa, J.A.S., Hallak, J.E., Classical hallucinogens and neuroimaging: a systematic review of human studies: hallucinogens and neuroimaging (2016) Neurosci. Biobehav. Rev, 71, pp. 715-728. , 27810345
• Drews, J., Drug discovery: a historical perspective (2000) Science, 287, pp. 1960-1964. , 10720314
• Egan, C.T., Herrick-Davis, K., Miller, K., Glennon, R.A., Teitler, M., Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors (1998) Psychopharmacology, 136, pp. 409-414. , 9600588
• Erowid, E., Erowid, F., Thyssen, S., (2017) Erowid experience vaults, , http://www.Erowid.org/exp
• Evans, J.M., Lopez, E., Roth, B.L., The NIMH psychoactive drug screening program’s Ki database: an on-line, searchable database of receptor-ligand affinity values (2001) Soc. Neurosci. Abstr, 27, p. 2076
• Fiorella, D., Rabin, R.A., Winter, J.C., The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: antagonist correlation analysis (1995) Psychopharmacology, 121, pp. 347-356. , 8584617
• Fontanilla, D., Johannessen, M., Hajipour, A.R., Cozzi, N.V., Jackson, M.B., Ruoho, A.E., The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator (2009) Science, 323, pp. 934-937. , 19213917
• Freedman, D., LSD: the bridge from human to animal (1984) Hallucinogens: Neurochemical, Behavioral, and Clinical Perspectives, pp. 203-226. , Jacobs B.L., (ed), New York, NY, Raven Press, “,”, ed
• Gaulton, A., Bellis, L.J., Bento, A.P., Chambers, J., Davies, M., Hersey, A., ChEMBL: a large-scale bioactivity database for drug discovery (2012) Nucleic Acids Res, 40, pp. D1100-D1107. , 21948594
• Glennon, R.A., Classical hallucinogens: an introductory overview (1994) NIDA Res. Monogr, 146, pp. 4-32. , 8742792
• Glennon, R.A., Lee, M., Rangisetty, J.B., Dukat, M., Roth, B.L., Savage, J.E., 2-Substituted tryptamines: agents with selectivity for 5-HT6 serotonin receptors (2000) J. Med. Chem, 43, pp. 1011-1018. , 10715164
• Glennon, R.A., Titeler, M., McKenney, J.D., Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984) Life Sci, 35, pp. 2505-2511. , 6513725
• Glennon, R.A., Young, R., Rosecrans, J.A., Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists (1983) Eur. J. Pharmacol, 91, pp. 189-196. , 6617740
• González-Maeso, J., Ang, R.L., Yuen, T., Chan, P., Weisstaub, N.V., López-Giménez, J.F., Identification of a serotonin/glutamate receptor complex implicated in psychosis (2008) Nature, 452, pp. 93-97. , 18297054
• González-Maeso, J., Weisstaub, N.V., Zhou, M., Chan, P., Ivic, L., Ang, R., Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior (2007) Neuron, 53, pp. 439-452. , 17270739
• Goutarel, R., Janot, M.M., (1956) U.S. Patent No. 2,813,873, , Washington, DC, U.S. Patent and Trademark Office
• Halberstadt, A.L., Lehmann-Masten, V.D., Geyer, M.A., Powell, S.B., Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice (2011) Psychopharmacology, 215, pp. 81-92. , 21153406
• Halevy, A., Norvig, P., Pereira, F., The unreasonable effectiveness of data (2009) IEEE Intell. Syst, 24, pp. 8-12
• Hanks, J.B., González-Maeso, J., Animal models of serotonergic psychedelics (2012) ACS Chem. Neurosci, 4, pp. 33-42. , 23336043
• Heim, R., Synthese und pharmakologie potenter 5-HT2A-rezeptoragonisten mit N-2-methoxybenzyl-partialstruktur (2004) Entwicklung Eines Neuen Struktur-Wirkungskonzepts. Ph.D. Thesis, , Berlin, Freie Universität Berlin
• Ho, B.T., Tansey, L.W., Balster, R.L., An, R., McIsaac, W.M., Harris, R.T., Amphetamine analogs. II. Methylated phenethylamines (1970) J. Med. Chem, 13, pp. 134-135. , 5412084
• Hofmann, A., (1980) LSD: My Problem Child, , Oxford, Oxford University Press
• Hollister, L.E., Hartman, A.M., Mescaline, lysergic acid diethylamide and psilocybin: comparison of clinical syndromes, effects on color perception and biochemical measures (1962) Compr. Psychiatry, 3, pp. 235-241. , 13908449
• Hoshino, T., Shimodaira, K., Uber die synthese des bufotenin-methyl-Äthers (5-methoxy-N-dimethyl-tryptamin) und bufotenins (synthesen in der indol-gruppe XV) (1936) Bull. Chem. Soc. Jap, 11, pp. 221-224
• Hysek, C.M., Domes, G., Liechti, M.E., MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions (2012) Psychopharmacology, 222, pp. 293-302. , 22277989
• Isbell, H., Miner, E.J., Logan, C.R., Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD 25) (1959) Psychopharmacology, 1, pp. 109-116. , 14405871
• Isbell, H., Wolbach, A.B., Wikler, A., Miner, E.J., Cross tolerance between LSD and psilocybin (1961) Psychopharmacologia, 2, pp. 147-159. , 13717955
• Kapur, S., Zipursky, R., Jones, C., Remington, G., Houle, S., Relationship between dopamine D2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia (2000) Am. J. Psychiatry, 157, pp. 514-520. , 10739409
• Kenakin, T., Principles: receptor theory in pharmacology (2004) Trends Pharmacol. Sci, 25, pp. 186-192. , 15063082
• Klema, V., Laub, A., The singular value decomposition: its computation and some applications (1980) IEEE Trans. Automat. Control, 25, pp. 164-176
• Kometer, M., Schmidt, A., Jäncke, L., Vollenweider, F.X., Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials and visual hallucinations (2013) J. Neurosci, 33, pp. 10544-10551. , 23785166
• Kometer, M., Vollenweider, F.X., Serotonergic hallucinogen-induced visual perceptual alterations (2016) Behavioral Neurobiology of Psychedelic Drugs. Current Topics in Behavioral Neurosciences, pp. 1-26. , Halberstadt A.L., lenweider F.X., Nichols D.E., (eds), Berlin, Springer, “,”, eds
• Kraehenmann, R., Pokorny, D., Aicher, H., Preller, K.H., Pokorny, T., Bosch, O.G., LSD increases primary process thinking via serotonin 2A receptor activation (2017) Front. Pharmacol, 8, p. 814. , a, 29167644
• Kraehenmann, R., Pokorny, D., Vollenweider, L., Preller, K.H., Pokorny, T., Seifritz, E., Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation (2017) Psychopharmacology, 234, pp. 2031-2046. , b, 28386699
• Landauer, T.K., (2006) Latent Semantic Analysis, , Hoboken, NJ, John Wiley & Sons Ltd
• Landauer, T.K., Dumais, S., Latent semantic analysis (2008) Scholarpedia, 3, p. 4356
• Leskovec, J., Rajaraman, A., Ullman, J.D., (2014) Mining of Massive Datasets, , Cambridge, Cambridge University Press
• Leung, A.Y., Paul, A.G., Baeocystin and norbaeocystin: new analogs of psilocybin from Psilocybe baeocystis (1968) J. Pharmacol. Sci, 57, pp. 1667-1671. , 5684732
• López-Giménez, J.F., González-Maeso, J., Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways (2018) Curr. Top. Behav. Neurosci, 36, pp. 45-73. , 28677096
• Mannich, C., Jacobsohn, W., Über oxyphenyl-alkylamine und dioxyphenyl-alkylamine (1910) Eur. J. Inorg. Chem, 43, pp. 189-197
• Manske, R.H., A synthesis of the methyltryptamines and some derivatives (1931) Can. J. Res, 5, pp. 592-600
• Markowitz, J.S., Brown, C.S., Moore, T.R., Atypical antipsychotics Part I: pharmacology, pharmacokinetics, and efficacy (1999) Ann. Pharmacother, 33, pp. 73-85. , 9972387
• Marona-Lewicka, D., Chemel, B.R., Nichols, D.E., Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen (2009) Psychopharmacology, 203, pp. 265-277. , 18604600
• Marona-Lewicka, D., Nichols, D.E., Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action (2007) Pharm. Biochem. Behav, 87, pp. 453-461. , 17618679
• McDowell, D.M., Kleber, H.D., MDMA: its history and pharmacology (1994) Psychiatr. Ann, 24, pp. 127-130
• McKenna, D.J., Repke, D.B., Lo, L., Peroutka, S.J., Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes (1990) Neuropharmacology, 29, pp. 193-198. , 2139186
• Moya, P.R., Berg, K.A., Gutiérrez-Hernandez, M.A., Sáez-Briones, P., Reyes-Parada, M., Cassels, B.K., Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors (2007) J. Pharmacol. Exp. Ther, 321, pp. 1054-1061. , 17337633
• Muthukumaraswamy, S.D., Shaw, A.D., Jackson, L.E., Hall, J., Moran, R., Saxena, N., Evidence that subanesthetic doses of ketamine cause sustained disruptions of NMDA and AMPA-mediated frontoparietal connectivity in humans (2015) J. Neurosci, 35, pp. 11694-11706. , 26290246
• Neubig, R.R., Spedding, M., Kenakin, T., Christopoulos, A., International union of pharmacology committee on receptor nomenclature and drug classification. XXXVIII. Update on terms and symbols in quantitative pharmacolog (2003) Pharmacol. Rev, 55, pp. 597-606. , 14657418
• Nichols, D.E., Structural correlation between apomorphine and LSD: involvement of dopamine as well as serotonin in the actions of hallucinogens (1976) J. Theoret. Biol, 59, pp. 167-177. , 7711
• Nichols, D.E., Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens (1986) J. Psychoactive Drugs, 18, pp. 305-313. , 2880944
• Nichols, D.E., Psychedelics (2016) Pharm. Rev, 68, pp. 264-355. , 26841800
• Nichols, D.E., Chemistry and structure-activity relationships of psychedelics (2017) Behavioral Neurobiology of Psychedelic Drugs. Current Topics in Behavioral Neurosciences, pp. 1-43. , Halberstadt A.L., lenweider F.X., Nichols D.E., (eds), Berlin, Springer, “,”, eds
• Nichols, D.E., Frescas, S., Marona-Lewicka, D., Kurrasch-Orbaugh, D.M., Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD) (2002) J. Med. Chem, 45, pp. 4344-4349. , 12213075
• Nutt, D.J., King, L.A., Nichols, D.E., Effects of Schedule I drug laws on neuroscience research and treatment innovation (2013) Nat. Rev. Neurosci, 14, pp. 577-585. , 23756634
• Paulke, A., Kremer, C., Wunder, C., Achenbach, J., Djahanschiri, B., Elias, A., Argyreia nervosa (Burm. f.): receptor profiling of lysergic acid amide and other potential psychedelic LSD-like compounds by computational and binding assay approaches (2013) J. Ethnopharmacol, 148, pp. 492-497. , 23665164
• Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Scikit-learn: machine learning in python (2011) J. Mach. Learn. Res, 12, pp. 2825-2830
• Popik, P., Layer, R.T., Skolnick, P., 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug (1995) Pharmacol. Rev, 47, pp. 235-253. , 7568327
• Preller, K.H., Herdener, M., Pokorny, T., Planzer, A., Kraehenmann, R., Stämpfli, P., The fabric of meaning and aq effects in LSD-induced states depend on serotonin 2A receptor activation (2017) Curr. Biol, 27, pp. 451-457. , 28132813
• Preller, K.H., Vollenweider, F.X., Phenomenology, structure, and dynamic of psychedelic states (2018) Curr. Top. Behav. Neurosci, 36, pp. 221-256. , 28025814
• Quednow, B.B., Kometer, M., Geyer, M.A., Vollenweider, F.X., Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers (2012) Neuropsychopharmacology, 37, pp. 630-640. , 21956447
• Rabin, R.A., Regina, M., Doat, M., Winter, J.C., 5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens (2002) Pharmacol. Biochem. Behav, 72, pp. 29-37. , 11900766
• Rätsch, C., (2005) The Encyclopedia of Psychoactive Plants: Ethnopharmacology and Its Applications, , New York, NY, Simon and Schuster
• Ray, T.S., Psychedelics and the human receptorome (2010) PLoS One, 5, p. e9019. , 20126400
• Repke, D.B., Ferguson, W.J., Bates, D.K., Psilocin analogs (1977) J. Heterocycl. Chem, 14, pp. 71-74. , 1. Synthesis of 3-[2-(dialkylamino) ethyl]-and 3-[2-(cycloalkylamino) ethyl] indol-4-ols
• Repke, D.B., Grotjahn, D.B., Shulgin, A.T., Psychotomimetic N-methyl-N-isopropyltryptamines.Effects of variation of aromatic oxygen substituents (1985) J. Med. Chem, 28, pp. 892-896. , 4009612
• Rickli, A., Luethi, D., Reinisch, J., Buchy, D., Hoener, M.C., Liechti, M.E., Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs) (2015) Neuropharmacology, 99, pp. 546-553. , 26318099
• Rickli, A., Moning, O.D., Hoener, M.C., Liechti, M.E., Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens (2016) Eur. Neuropsychopharmacol, 26, pp. 1327-1337. , 27216487
• Roth, B.L., Baner, K., Westkaemper, R., Siebert, D., Rice, K.C., Steinberg, S., Salvinorin A: a potent naturally occurring nonnitrogenous κ opioid selective agonist (2002) Proc. Natl. Acad. Sci. U S A, 99, pp. 11934-11939. , 12192085
• Roth, B.L., Sheffler, D.J., Kroeze, W.K., Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia (2004) Nat. Rev. Drug. Discov, 3, pp. 353-359. , 15060530
• Sahlgren, M., The distributional hypothesis (2008) Ital. J. Disab. Stud, 20, pp. 33-53
• Sanders-Bush, E., Burris, K.D., Knoth, K., Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis (1988) J. Pharmacol. Exp. Ther, 246, pp. 924-928. , 2843634
• Sanz, C., Zamberlan, F., Erowid, E., Erowid, F., Tagliazucchi, E., The experience elicited by hallucinogens presents the highest similarity to dreaming within a large database of psychoactive substance reports (2018) Front. Neurosci, 12, p. 7. , 29403350
• Schartner, M.M., Carhart-Harris, R.L., Barrett, A.B., Seth, A.K., Muthukumaraswamy, S.D., Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin (2017) Sci. Rep, 7, p. 46421. , 28422113
• Schenberg, E.E., de Castro Comis, M.A., Alexandre, J.F.M., Tófoli, L.F., Chaves, B.D.R., da Silveira, D.X., A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment (2017) J. Psychedelic Stud, 1, pp. 74-83
• Schenberg, E.E., de Castro Comis, M.A., Chaves, B.R., da Silveira, D.X., Treating drug dependence with the aid of ibogaine: a retrospective study (2014) J. Psychopharmacol, 28, pp. 993-1000. , 25271214
• Schultes, R.E., Hofmann, A., (1979) Plants of the Gods: Origins of Hallucinogenic Use, , Rochester, Healing Arts Press
• Seeman, P., Ko, F., Tallerico, T., Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics (2005) Mol. Psychiatry, 10, pp. 877-883. , 15852061
• Seifert, R., Functional selectivity of G-protein-coupled receptors: from recombinant systems to native human cells (2013) Biochem. Pharmacol, 86, pp. 853-861. , 23933388
• Sheridan, R.P., Miller, M.D., Underwood, D.J., Kearsley, S.K., Chemical similarity using geometric atom pair descriptors (1996) J. Chem. Inf. Comput. Sci, 36, pp. 128-136
• Shulgin, A.T., Psychotomimetic amphetamines: methoxy 3,4 dialkoxyamphetamines (1964) Experientia, 20, pp. 366-367. , 5855670
• Shulgin, A.T., Bunnell, S., Sargent, T., The psychotomimetic properties of 3,4,5-trimethoxyamphetamine (1961) Nature, 189, pp. 1011-1012
• Shulgin, A.T., Carter, M.F., N,N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity (1979) Commun. Psychopharmacol, 4, pp. 363-369. , 6949674
• Shulgin, A., Shulgin, A., (1995) PIHKAL: A Chemical Love Story, , Berkeley, Transform Press
• Shulgin, A., Shulgin, A., (1997) TIHKAL: The Continuation, , Berkeley, Transform Press
• Shulgin, A.T., Sargent, T., Naranjo, C., Structure-activity relationships of one-ring psychotomimetics (1969) Nature, 221, pp. 537-541. , 5789297
• Simmler, L.D., Buser, T.A., Donzelli, M., Schramm, Y., Dieu, L.H., Huwyler, J., Pharmacological characterization of designer cathinones in vitro (2013) Br. J. Pharmacol, 168, pp. 458-470. , 22897747
• Spath, E., Ueber die anhalonium-alkaloide (1919) I. Anhalin und Mezcalin. Monatsh. Chem, 40, pp. 129-152
• Spencer, D.G., Jr., Glaser, T., Traber, J., Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N dimethyltryptamine (1987) Psychopharmacology, 93, pp. 158-166. , 3122248
• Stephenson, R.P., A modification of receptor theory (1956) Br. J. Pharmacol. Chemother, 11, pp. 379-393. , 13383117
• Studerus, E., Gamma, A., Kometer, M., Vollenweider, F.X., Prediction of psilocybin response in healthy volunteers (2012) PLoS One, 7, p. e30800. , 22363492
• Studerus, E., Gamma, A., Vollenweider, F.X., Psychometric evaluation of the altered states of consciousness rating scale (OAV) (2010) PLoS One, 5, p. e12412. , 20824211
• Sweetnam, P.M., Lancaster, J., Snowman, A., Collins, J.L., Perschke, S., Bauer, C., Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine’s putative anti-addictive activity (1995) Psychopharmacology, 118, pp. 369-376. , 7568622
• Urban, J.D., Clarke, W.P., von Zastrowm, M., Nichols, D.E., Kobilka, B., Weinstein, H., Functional selectivity and classical concepts of quantitative pharmacology (2007) J. Pharmacol. Exp. Ther, 320, pp. 1-13. , 16803859
• van Amsterdam, J., Opperhuizen, A., van den Brink, W., Harm potential of magic mushroom use: a review (2011) Regul. Toxicol. Pharmacol, 59, pp. 423-429. , 21256914
• Vidal, D., Mestres, J., In silico receptorome screening of antipsychotic drugs (2010) Mol. Inform, 29, pp. 543-551. , 27463332
• Vollenweider, F.X., Vollenweider-Scherpenhuyzen, M.F.I., Bäbler, A., Vogel, H., Hell, D., Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998) Neuroreport, 9, pp. 3897-3902. , 9875725
• Wacker, D., Wang, S., McCorvy, J.D., Betz, R.M., Venkatakrishnan, A.J., Levit, A., Crystal structure of an LSD-bound human serotonin receptor (2017) Cell, 168, pp. 377.e12, 389.e12. , 28129538
• Wall, M.E., Rechtsteiner, A., Rocha, L.M., Singular value decomposition and principal component analysis (2003) A Practical Approach to Microarray Data Analysis, pp. 91-109. , Berrar D.P., Dubitzky W., Granzow M., (eds), Norwell, MA, Kluwer Academic Publishers, “,”, eds
• Watts, V.J., Lawler, C.P., Fox, D.R., Neve, K.A., Nichols, D.E., Mailman, R.B., LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors (1995) Psychopharmacology, 118, pp. 401-409. , 7568626
• Willett, P., Similarity-based virtual screening using 2D fingerprints (2006) Drug Discov. Today, 11, pp. 1046-1053. , 17129822
• Winter, J.C., Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines and tryptamines (2009) Psychopharmacology, 203, pp. 251-263. , 18979087
• Winter, J.C., Eckler, J.R., Rabin, R.A., Serotonergic/glutamatergic interactions: the effects of mGlu 2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli (2004) Psychopharmacology, 172, pp. 233-240. , 14598016
• Wise, R.A., Wang, B., You, Z.B., Cocaine serves as a peripheral interoceptive conditioned stimulus for central glutamate and dopamine release (2008) PLoS One, 3, p. e2846. , 18682722
• Wolbach, A.B., Jr., Miner, E.J., Isbell, H., Comparison of psilocin with psilocybin, mescaline and LSD-25 (1962) Psychopharmacologia, 3, pp. 219-223. , 14007905
• Zhou, L., Bohn, L.M., Functional selectivity of GPCR signaling in animals (2014) Curr. Opin. Cell Biol, 27, pp. 102-108. , 24680435

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------